JPML will hold a hearing on January 25, 2024, at the Central District of California Courthouse to discuss the consolidation of all GLP-1 stomach paralysis lawsuits , including those involving Ozempic, Wegovy, Mounjaro, and similar cases, to assess if centralizing these suits is appropriate
Clinical Benefits of GLP-1 Receptor Agonists and Combined Therapies on MASLD Comorbidities The clinical benefits of GLP-1 receptor agonists and combined therapies on MASLD comorbidities are presented in Figure 4
Both require consistent use, dose tolerance, and the discipline to train and eat protein while losing weight
A foundational nutritional plan is an important first step for individuals taking GLP-1 agonists
We need a large prospective study to determine whether use of these GLP-1 drugs can help many women avoid developing the disease at all
A P-value of less than 0.05 was considered statistically significant